Ignite Creation Date:
2025-12-24 @ 4:36 PM
Ignite Modification Date:
2026-03-20 @ 12:46 PM
Study NCT ID:
NCT00184366
Status:
TERMINATED
Last Update Posted:
2012-01-19
First Post:
2005-09-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Classification and Characterization of Patients Treated With Efalizumab for Plaque Psoriasis
Sponsor:
Norwegian University of Science and Technology
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ROCAC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None